Peter Murray, Editor

About the Author Peter Murray, Editor


How Analysts View Netflix, Inc. (NFLX) Post 3Q:17 Results

In a research note released Tuesday, Aegis analyst Victor Anthony reiterated a Hold rating on shares of Netflix (NASDAQ:NFLX) with a price target of …

Cantor Pounds the Table on Valeant Pharmaceuticals Intl Inc (VRX)

Fears about financial control should be a buying opportunity in Valeant stock, says Cantor.

Maxim Pounds the Table on MannKind Corporation (MNKD)

Will Mannkind file bankruptcy? Jason Kolbert says no.

Fixed: Canaccord Highlights Upcoming Catalysts For Palatin Technologies, Inc. (PTN) Bulls

John Newman continues to expect NDA in 2018 for bremelanotide, while pipeline moves forward.

Walt Disney Co’s (DIS) Soggy Outlook Tests Investors Patience; Credit Suisse Weighs in

Credit Suisse remains bullish on Walt Disney despite earnings warning.

The Medicines Company (MDCO): How Much Vabomere Worth?

This morning, The Medicines Company (NASDAQ:MDCO) reported that the FDA approved its urinary tract infection treatment Vabomere, a move the drug maker hopes will bolster …

The Medicines Company (MDCO): Inclisiran Shows Momentum on Longer-Term Data, Oppenheimer Weighs in

Yesterday, at the European Society of Cardiology (ESC) Congress 2017 in Barcelona, The Medicines Company (NASDAQ:MDCO) unveiled positive one-year data from the 501-patient …

Guess?, Inc. (GES) Q2: Bulls Win, What’s Next?

Guess?, Inc.

Why Maxim Raised Price Target for Adamis Pharmaceuticals Corp

Adamis Stock Can Reach $13 as Symjepi Deal Is Imminent

Alibaba Group Holding Ltd (BABA) Fundamentals Remain Impressive: Mark Mahaney

Mark Mahaney of RBC Capital rates stocks in the internet sector and is one of the top 20 analysts rated on TipRanks. Yesterday, Mahaney …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts